Horizon Therapeutics Public Ltd COMPANY

DUBLIN, L2 How do I update this listing?

Horizon Therapeutics Public LTD Company is based out of Dublin. Horizon Pharma, Inc., a biopharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.Whalewisdom has at least 227 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2013-12-09. The notice included securities offered of Debt

Create Alert

Contact Info

horizon therapeutics public ltd company
CONNAUGHT HOUSE, 1ST FLOOR
DUBLIN L2    4

Business Phone: 011-353-1-772-2100
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2013-12-09 D PHARMACEUTICALS Debt 150,000,000 150,000,000 0
2012-03-19 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 65,934,397 65,934,397 0
2012-03-08 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 32,772 32,772 0
2011-06-17 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 637,500 637,500 0
2011-05-04 D/A PHARMACEUTICALS Equity,Debt 37,500,000 36,783,085 716,915
2011-01-21 D/A PHARMACEUTICALS Equity,Debt 35,500,000 35,030,345 469,655
2010-05-24 D PHARMACEUTICALS Equity INDEFINITE 0 INDEFINITE
2010-05-24 D PHARMACEUTICALS Equity,Debt 30,000,000 20,000,000 10,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
GINO SANTINI subscription required
    DIRECTOR
HUBERT BIRNER subscription required
    DIRECTOR
JEAN-FRANCOIS FORMELA subscription required
    DIRECTOR
JEFF HIMAWAN subscription required
    DIRECTOR
JEFFREY W. BIRD subscription required
    DIRECTOR
LOUIS C. BOCK subscription required
    DIRECTOR
MICHAEL GREY subscription required
    DIRECTOR
PETER JOHANN subscription required
    DIRECTOR
ROBERT DE VAERE subscription required
    EXECUTIVE OFFICER
RONALD PAULI subscription required
    DIRECTOR
TIMOTHY P. WALBERT subscription required
    EXECUTIVE OFFICER DIRECTOR

Elevate your investments